Interleukin-27 Ameliorates Atherosclerosis in ApoE-/- Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
Atherosclerosis, which is characterized by chronic inflammation in the arterial wall, is driven by immune cells and cytokines. Recent evidence indicated that interleukin (IL)-27 showed pleiotropic properties in immune diseases. However, precise mechanisms of IL-27, especially in atherosclerosis rema...
Saved in:
| Main Authors: | Wenbin Xu, Ruirui Zhu, Zhengfeng Zhu, Kunwu Yu, Yue Wang, Yan Ding, Jian Yu, Hongxia Tang, Qiutang Zeng, Yucheng Zhong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2022/2054879 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
by: Ruirui Zhu, et al.
Published: (2016-12-01) -
Dendritic cells immunotargeted therapy for atherosclerosis
by: Zhaohui Li, et al.
Published: (2025-02-01) -
RETRACTED ARTICLE: Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells
by: Hengshan Zhu, et al.
Published: (2015-11-01) -
Retraction Note: Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells
by: Hengshan Zhu, et al.
Published: (2025-06-01) -
Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
by: Ruirui Zhu, et al.
Published: (2015-01-01)